A new study suggests that HIV infected patients should start antiretroviral treatment earlier. Here’s the editor’s note accompanying the article in today’s online version of the Lancet: “When to start antiretroviral treatment has been a problem for physicians dealing with patients with HIV infection. Most commonly the decision is based on CD4 counts, […]
The meeting in Beijing last week of health ministers from high-burden MDR and XDR TB countries has produced some significant results, at least on paper. Perhaps most notably, participants “committed to help mobilize $2 billion needed over the next two years to adequately finance the TB and M/XDR-TB response from both domestic and international resources […]
HIV
The following is a guest post by Maureen Luba Milambe, African Regional Advocacy Advisor, AVAC On Tuesday (June 8), the UN General Assembly voted overwhelmingly to […]
Tuberculosis
The publication of trial data showing a four-month treatment regimen for tuberculosis that is not resistant to first-line medicines as effective as the currently widely prescribed […]
Research & Development
By Mitchell Warren, executive director, AVAC In February 2020, just as the COVID pandemic began its rapid global spread, a major HIV vaccine trial called HVTN […]
Policy
By Karen Carvajal, M.D. Over the course of human history we have come a long way in our fight against the threat of infectious diseases and, […]